Recent YSCC Discoveries

In a new study, Yale researchers identified drug candidates that reverse disrupted behaviors in zebrafish carrying mutations in autism risk genes.

Researchers have made miniature versions of the pineal gland. They’re helping explain the sleep challenges that come with conditions like Angelman syndrome and autism.

The researchers joined the Immune Cell Reprogramming team, which aims to harness immune cells for health surveillance and disease treatment.

In the lab of Erica Herzog, MD, PhD, scientists are working to cure pulmonary fibrosis, researching the condition's underlying mechanisms to inform approaches for prevention and treatment.

The American Association for the Advancement of Science has elected five members of the Yale community as part of its latest class of fellows.

The Connecticut Academy of Science and Engineering (CASE), announces the election of thirty-six of Connecticut’s leading experts in science, technology, engineering, mathematics, and medicine to membership in the Academy. The new members will be introduced at the Academy’s 51st Annual Dinner to be held at the Aqua Turf Club in Plantsville on May 19, 2026.

Two Yale Department of Psychiatry affiliates attended the BD2 Funded Investigators Community Meeting March 11-13 in Fort Lauderdale, Fla.

On Friday, March 20th, the Precision Medicine in Cancer Program at Yale Cancer Center hosted a day long workshop focused on real-world applications of AI across the cancer care continuum, from bench to clinical implementation to population health.

Berna Sozen, PhD, Assistant Professor of Genetics at Yale School of Medicine, has been named a recipient of the 2026 Vilcek Prize for Creative Promise in Biomedical Science. Awarded annually by the Vilcek Foundation, the prize honors immigrant contributions to science and culture in the United States.